![Carla Spina](https://cixsummit.com/wp-content/uploads/2024/03/Untitled-design.jpg)
![Carla Spina](https://cixsummit.com/wp-content/uploads/2024/03/54c0d2516608-noa_logo_vector_e98074-1.jpg)
Carla Spina
CEO | Noa Therapeutics
Carla Spina, PhD. CEO & Co-Founder. Carla over 20 years of experience in life science. She led the development of novel topical antimicrobials, from discovery through to Phase Ib/IIa clinical study, and the development and commercialization of 6six Class II/III drug-device products, resulting in global license through 3M. She leverages a foundational knowledge in chemistry from her Ph.D. at McGill University with Dr. D.S. Bohle, Canadian Chair in Bioinorganic chemistry.